Recipharm Holds 91% Consort Stake, To Implement Compulsory Acquisition
Recipharm Holds 91% Consort Stake, To Implement Compulsory Acquisition
Read moreFri, 14th Oct 2016 12:23
Recipharm Holds 91% Consort Stake, To Implement Compulsory Acquisition
Read more(Sharecast News) - Consort Medical: RBC Capital Markets upgrades to sector performer with a target price of 1,010p.
Read moreRecipharm Lowers Acceptance Condition; Consort Offer Now Unconditional
Read moreRecipharm To Make No Further Changes To Consort Medical Offer
Read moreRecipharm Extends Consort Medical Offer Deadline To February 4
Read moreRecipharm Buys 10% Of Takeover Target Consort Medical
Read moreRecipharm's Consort Medical Takeover Clears German Regulatory Hurdle
Read more(Sharecast News) - Polymetal International: Berenberg upgrades to buy with a target price of 1,480p.
Read moreRecipharm Extends Consort Medical Offer Deadline To January 23
Read moreUK BROKER RATINGS SUMMARY: Lloyds, National Grid And Barratt Cut
Read moreConsort Medical First Half Profit Falls Due To Cramlington Incident
Read moreUK Earnings, Trading Statements Calendar - Next 7 Days
Read moreUK BROKER RATINGS SUMMARY: Jefferies Raises Intertek; UBS Cuts Segro
Read more(Sharecast News) - Croda International: Liberum Capital downgrades to hold with a target price of 4,400p.
Read moreLONDON MARKET MIDDAY: Stocks Rise On "Constructive" US-China Talks
Read more